Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Lanfranchi C, Orena BS, Gramegna A, Blasi F, Colombo C. Alicandro G, et al. Among authors: lanfranchi c. J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16. J Cyst Fibros. 2022. PMID: 35256306 Free PMC article. No abstract available.
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes.
Grancini V, Gramegna A, Zazzeron L, Alicandro G, Porcaro LL, Piedepalumbo F, Lanfranchi C, Daccò V, Orsi E, Blasi F. Grancini V, et al. Among authors: lanfranchi c. Diabetes Metab. 2023 Sep;49(5):101466. doi: 10.1016/j.diabet.2023.101466. Epub 2023 Aug 1. Diabetes Metab. 2023. PMID: 37536552
Sydenham's chorea: A diagnosis not to miss.
Cappellari AM, Lanfranchi C, Bruschi G, Petaccia A. Cappellari AM, et al. Among authors: lanfranchi c. Rev Neurol (Paris). 2022 Oct;178(8):855-856. doi: 10.1016/j.neurol.2022.04.003. Epub 2022 Sep 20. Rev Neurol (Paris). 2022. PMID: 36137829 No abstract available.
[SGLT2 inhibitors : promises, but for whom ?].
Lanfranchi C, Jolivot PA, Wermeille J. Lanfranchi C, et al. Rev Med Suisse. 2024 Dec 4;20(898):2307-2311. doi: 10.53738/REVMED.2024.20.898.2307. Rev Med Suisse. 2024. PMID: 39639620 French.
23 results